Home › FDA approves once-monthly Abilify for schizophrenia
 

Keywords :   


FDA approves once-monthly Abilify for schizophrenia

2013-03-01 04:10:30| Biotech - Topix.net

U.S. regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck .

Tags: fda approves schizophrenia fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Atlantic Tropical Weather Outlook
28.06Incomes have risen 'at a crawl' says think tank
28.06Eastern North Pacific Tropical Weather Outlook
28.06Are rainy days ahead for cloud computing?
28.06Electric car battery charges in under five minutes in track test
28.06Debt relief orders can write off up to 50,000
27.06Strike could force Tata plant to shut next week
27.06Eastern North Pacific Tropical Weather Outlook
More »